
Virus de la grippe
Les inhibiteurs du virus de la grippe sont des composés qui interfèrent avec la réplication et la propagation des virus de la grippe. Ces inhibiteurs sont essentiels pour rechercher des stratégies antivirales, comprendre le cycle de vie du virus de la grippe et développer des traitements et des vaccins efficaces. Les inhibiteurs de la grippe peuvent cibler différentes étapes du processus de réplication virale, y compris l'entrée virale, la réplication et la libération. Chez CymitQuimica, nous offrons une large gamme d'inhibiteurs de haute qualité du virus de la grippe pour soutenir vos recherches en virologie, maladies infectieuses et développement de médicaments antiviraux.
300 produits trouvés pour "Virus de la grippe"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
Influenza virus-IN-7
CAS :Influenza virus-IN-7: oral endonuclease inhibitor for flu research.Formule :C29H26F2N4O7SCouleur et forme :SolidMasse moléculaire :612.6Crystal Violet
CAS :Crystal Violet (Hexamethylpararosaniline chloride) is a triarylmethane dye that is a mixture of violet rosanilinis, with antibacterial and antifungal effects.Formule :C25H30ClN3Degré de pureté :99.6% - ≥98%Couleur et forme :Greenish Free Flowing Powder Solid PowderMasse moléculaire :407.98P9R
CAS :P9R is an antiviral peptide with broad-spectrum activity against coronaviruses (SARS-CoV-2, MERS-CoV, and SARS-CoV), influenza A H1N1 virus (A(H1N1)pdm09), influenza A H7N9 virus (A(H7N9) virus), and rhinovirus. It binds directly to viruses and inhibits virus-host endosomal acidification. P9R significantly protects mice from infection by influenza A H1N1 virus (A(H1N1)pdm09) without leading to resistant viruses. P9R is applicable in studying pH-dependent respiratory viruses.Formule :C144H232N52O35S5Couleur et forme :SolidMasse moléculaire :3412.03Neuraminidase-IN-16
Neuraminidase-IN-16 (43b) inhibits H5N1, H5N8, H1N1, H3N2, H5N1-H274Y, H1N1-H274Y neuraminidases; IC50: 0.031-10.08 μM.Formule :C26H35FN2O4Couleur et forme :SolidMasse moléculaire :458.57Trifluoromethyl-tubercidin
CAS :TFMT blocks MTr1 at SAM-binding site, curbing influenza virus replication with low toxicity in mice.
Formule :C12H13F3N4O4Degré de pureté :99.85% - 99.9%Couleur et forme :SoildMasse moléculaire :334.25ATV03
ATV03 is an antiviral agent exhibiting potent activity against both type A and type B influenza viruses. It inhibits the type A (H3N2) and type B influenza viruses with EC50 values of 0.78 nM and 2.02 nM, respectively. The mechanism of action of ATV03 involves the inhibition of the polymerase acidic protein (PA) and RNA-dependent RNA polymerase (RdRp), as well as the disruption of nucleoprotein, thereby exerting its antiviral effects against influenza.Formule :C24H20FN3O5Couleur et forme :SolidMasse moléculaire :449.43CEF4
CAS :CEF4 is a peptide derived from amino acids (aa) 342-351 of the influenza A virus nucleocapsid protein.Formule :C53H93N15O13Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :1148.4Anti-IAV agent 1
Anti-IAV agent 1 -1a: Orally active, fights influenza A. IC50: 0.03μM for H1N1, 0.06μM for resistant strains.Formule :C28H28FN9O3Couleur et forme :SolidMasse moléculaire :557.58Influenza HA (307-319)
CAS :Influenza Hemagglutinin is an HLA-DRB 0101-restricted epitope from influenza hemagglutinin (307-319).Formule :C69H118N18O19Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :1503.78HA-IN-1
HA-IN-1 (compound 5g), a high-affinity Hemagglutinin (HA) ligand, targets the trypsin cleavage site of HA to inhibit HA-mediated membrane fusion and decreaseFormule :C42H35NO6Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :649.73HAA-09
CAS :HAA-09: oral anti-influenza with EC50 of 0.03μM; inhibits PB2, IC50 0.06μM; non-toxic, blocks virus replication.Formule :C17H18F2N6O2Couleur et forme :SolidMasse moléculaire :376.36Methyl brevifolincarboxylate
CAS :Methyl brevifolincarboxylate is an influenza inhibitor targeting PB2 with IC50s of 27.16μM (H1N1) and 33.41μM (H3N2), and has antioxidant activity.Formule :C14H10O8Couleur et forme :SolidMasse moléculaire :306.22Herquline A
CAS :Herquline A, a P. herquei alkaloid, blocks influenza A-induced cell death (IC50 = 10 μg/ml) and viral replication; hinders ADP/PAF-induced platelet clumping.Formule :C19H26N2O2Couleur et forme :SolidMasse moléculaire :314.429PROTAC Hemagglutinin Degrader-1
PROTAC Hemagglutinin Degrader-1 (V3) degrades influenza HA potently (DC50 1.44 μM) with broad-spectrum antiviral effects.Formule :C61H93N5O9SCouleur et forme :SolidMasse moléculaire :1072.48PA (224-233), Influenza
CAS :PA (224-233), Influenza is a 10-aa peptide, which is a fragment of polymerase 2 protein in Influenza a virus.Formule :C53H80N14O17Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :1185.29Eckol
CAS :Eckol inhibits ultraviolet B-induced cell damage by a decrease in oxidative stress in human keratinocytes.Formule :C18H12O9Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :372.28Cobalt protoporphyrin IX
CAS :Cobalt Protoporphyrin IX serves as a potent, specific inducer of heme oxygenase-1 (HO-1) and demonstrates broad-spectrum antiviral effects against Influenza AFormule :C34H32CoN4O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :619.58Triperiden
CAS :Triperiden: an anticholinergic, anti-Parkinson's drug; inhibits influenza by blocking haemagglutinin changes.Formule :C21H30ClNOCouleur et forme :SolidMasse moléculaire :347.93Oseltamivir-acetate
CAS :Oseltamivir-acetate, an impurity of Oseltamivir, is a recommended neuraminidase inhibitor for both the treatment and prophylaxis of influenza A and B[1][2].Formule :C18H30N2O5Couleur et forme :SolidMasse moléculaire :354.44PB2
CAS :PB2 is a TCEP-like compound that boosts RGC survival post-axotomy, effective even in tiny amounts, and offers improved permeability and neuroprotection.Formule :C16H20BO2PCouleur et forme :SolidMasse moléculaire :286.12

